Delivery Order SPE2DB20D3303-SPE2DB25FA2MW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 25 mg tablets (30-count units). The contract, which is a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units) with a ceiling value of $8,026.53. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract vehicle with the DLA. The award was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-tablet units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, executed without a set-aside designation, was competitively awarded and represents a transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract...
- The Defense Logistics Agency awarded a $13,254.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 25 mg tablets (30-count unit of use packaging). The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-unit packages) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Promacta 12.5 mg tablets (30-count units) under a firm fixed price contract valued at $13,251.75, with completion targeted for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $17,672.24 delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-unit package) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a $12,029.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a continuation of the company's pharmaceutical supply services to the federal government. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,029.63 to supply Promacta 75 mg tablets (30-count units) with a completion deadline of May 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on April 24, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2MWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,836.12 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets (30-count packaging) with a completion date of September 4, 2025. The competitive, firm fixed-price award was issued on August 13, 2025, with no set-aside designation. AmerisourceBergen will perform the work at its corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Promacta, a medication used in treating immune thrombocytopenia, reflects the contractor's ongoing role as a critical pharmaceutical vendor supporting federal medical procurement needs through the DLA's supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 8/13/25 |